Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
BALANCE - Beginning of the period (Audited) at Sep. 30, 2013	$ (2,160,000)us-gaap_StockholdersEquity	$ 92,700	$ 54,298,000	$ (56,550,700)
BALANCE - Beginning of the period (Audited) (in shares) at Sep. 30, 2013		92,716,562
Stock-based compensation	364,000	0	364,000	0
Stock issued for private placement shares purchases	466,000	1,900	464,100	0
Stock issued for private placement shares purchases (in shares)		1,900,000
Stock issued in lieu of cash to creditors	361,600	1,500	360,100	0
Stock issued in lieu of cash to creditors (in shares)		1,446,380
Net income loss	135,100us-gaap_NetIncomeLoss	0	0	135,100
Balance at end of the period at Dec. 31, 2013	(833,300)us-gaap_StockholdersEquity	96,100	55,486,200	(56,415,600)
Balance at end of the period (in shares) at Dec. 31, 2013		96,062,942
BALANCE - Beginning of the period (Audited) at Sep. 30, 2014	(1,761,600)us-gaap_StockholdersEquity	101,700	57,350,200	(59,213,500)
BALANCE - Beginning of the period (Audited) (in shares) at Sep. 30, 2014		101,667,409
Stock-based compensation	62,500	0	62,500	0
Warrant Valuation - Investor Relations	21,600	0	21,600	0
Net income loss	(874,600)us-gaap_NetIncomeLoss	0	0	(874,600)
Balance at end of the period at Dec. 31, 2014	$ (2,552,100)us-gaap_StockholdersEquity	$ 101,700	$ 57,434,300	$ (60,088,100)
Balance at end of the period (in shares) at Dec. 31, 2014		101,667,409

- Definition

This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".

+ References + Details

- Definition

Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details